Zamplo
Zamplo is a Calgary-based digital health SaaS company that provides researchers, healthcare providers, and pharmaceutical sponsors with a remote patient-monitoring and patient-reported outcomes platform, including the Zamplo Research web product, the patient-facing Zamplo App, and condition-specific patient support deployments such as the Alberta mBC Support Platform.
- Company typePrivate
- Founded2020
- HeadquartersCalgary, Canada
- Headcount1–10
- GTM typeB2B and B2C
- OfferingSoftware
What Zamplo does
Zamplo is a Calgary-based digital health company that has built a point-of-care platform for remote patient monitoring and patient-reported outcomes (PROs) collection, organized around two core products: Zamplo Research, a SaaS platform that enables researchers, healthcare organizations, and pharmaceutical companies to configure PROMs surveys, capture wearable device data, run e-consent workflows, and export real-time CSV datasets; and the Zamplo App, a patient-facing iOS/Android and desktop application that lets individuals and caregivers track symptoms, medications, activities, and health documents and retain ownership of their data after a study completes. The platform also supports disease-specific deployments such as the Alberta Metastatic Breast Cancer (mBC) Support Platform, co-designed with oncologist Dr. Nancy Nixon, signaling an extension of the core technology into condition-branded patient support programs.
Underlying technology includes direct wearable device integrations with real-time data upload, one-step e-consent workflows, configurable routine and survey templates, REB/ethics submission templates, real-time CSV data extraction for authorized users, and AI/ML-driven predictive analytics and personalized care recommendations. Zamplo is SOC 2 Type 2 compliant and PIPEDA compliant, with all data stored on AWS in Montreal, Canada; the company states it does not have access to identifiable study data.
The business model is a quote-based B2B SaaS subscription priced by participant count and project duration, structured as multi-year contracts, sold directly to clinical researchers, healthcare providers, pharmaceutical patient-support programs, and patient-support platforms. Disclosed named accounts include University Health Network, University of Calgary, Institute of Health Economics, AstraZeneca, and the Alberta mBC program. The company is privately held, has raised approximately $2.5M CAD across disclosed rounds since 2018 (largest being a ~$1.1M round in January 2024 from Accelerate Fund and ScaleGood Fund LP, followed by a smaller $150K round in January 2025), operates with 1–10 employees, and is led by co-founder/CEO Mike Urquhart alongside co-founders Shaneel Pathak and Cory Kapser (fractional CTO).
Zamplo firmographics
Firmographics- Name
- Zamplo
- Legal name
- Zamplo Inc.
- Website
- https://zamplo.org
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Zamplo is a Calgary-based digital health SaaS company that provides researchers, healthcare providers, and pharmaceutical sponsors with a remote patient-monitoring and patient-reported outcomes platform, including the Zamplo Research web product, the patient-facing Zamplo App, and condition-specific patient support deployments such as the Alberta mBC Support Platform.
- Ownership category
- akta.pro rank
Zamplo industry classification
Industry- Product category
- Digital health / Patient-reported outcomes software
- NAICS
- Computer Systems Design and Related Services (54151)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Oncology Remote Symptom Monitoring & Care Navigation (HLALAFAD)
- akta.pro secondary industry
- Clinical Trial Monitoring Support (On-site/Remote) (HLAGACAG)
Keywords
Where Zamplo is headquartered
LocationHeadquarters
- HQ city
- Calgary
- HQ country
- Canada
- HQ region
- North America
Offices1 record
Markets served
Zamplo business model
Business model- GTM type
- B2B and B2C
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations
Revenue model
- Zamplo Research Platform Subscription: SaaS subscription model for researchers and healthcare organizations to monitor patient-reported outcome measures. Pricing is determined based on number of participants and project duration, with additional services including custom onboarding, recruitment support, and in-app consent.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | Quote-based pricing tailored to project scope |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
Zamplo product offering
Product offeringCore offering
Zamplo provides a connected health SaaS platform that captures patient-reported outcomes, wearable data, and e-consent remotely to support clinical research, remote patient monitoring, and patient support programs. Its two core offerings are Zamplo Research, a web-based platform for healthcare researchers, providers, and pharmaceutical companies to configure PROMs surveys and extract real-time CSV data, and the Zamplo App, a consumer mobile and desktop application that lets patients and caregivers track symptoms, medications, activities, and health documents. The platform supports specialized deployments such as the Alberta Metastatic Breast Cancer (mBC) Support Platform.
Product overview
Zamplo is a connected health platform consisting of two primary products: Zamplo Research, a researcher-facing platform for collecting real-world patient-reported outcomes and wearable data; and the Zamplo App, a patient-facing application for individuals and caregivers to track symptoms, medications, activities, and health documents. The platform also supports specialized patient support programs such as the Alberta Metastatic Breast Cancer (mBC) Support Platform. All data is encrypted and stored in Canada.
Differentiator
Problem solved
Functional benefit
Brands
- Zamplo Research: A research platform for collecting real-world data on patient quality of life and monitoring patient-reported outcome measures (PROMs) data in clinical studies.
- Zamplo App
- Alberta Metastatic Breast Cancer (mBC) Support Platform
Products and services
- Zamplo Research A web-based SaaS research platform for researchers, healthcare practitioners, partner organizations, and pharmaceutical companies to remotely collect and monitor patient-reported outcome measures (PROMs), configure standardized questionnaires, share educational material, implement and validate care delivery approaches, and extract near real-time health data.
- Zamplo App A patient-facing mobile (iOS/Android) and desktop application that empowers individuals and caregivers to track symptoms, medications, activities, health data, and documents; create journal entries; set medication and routine reminders; graph health trends; and generate reports to share with care teams.
- Alberta Metastatic Breast Cancer (mBC) Support Platform A customized support platform built on the Zamplo App, co-designed with metastatic breast cancer patients and Dr. Nancy Nixon, allowing individuals living with mBC and their caregivers in Alberta to track medications, supplements, symptoms, activities, and health-related data; prepare for appointments; access credible resources; and connect with others living with metastatic breast cancer.
Quantifiable outcome
- Immediate healthcare interventions triggered in 37.5% of instances based on patient-reported outcome data
- +3 more outcomes
Companies that use Zamplo
Customer profileNamed customers5 records
Segments4 records
Ideal customer profiles3 records
Zamplo technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability1 record
Feature6 records
Zamplo partnerships and signals
Strategic signalScale indicators4 records
Recent moves5 records
Expansion highlights6 records
Zamplo competitors and assessment
Company assessmentDirect peers
- Castor: Castor offers a cloud-based clinical research platform with electronic data capture (EDC) and a PRO/ePRO module for decentralized trials. Direct overlap with Zamplo Research for academic and clinical study teams collecting patient-reported outcomes.
- Clario: Clario provides eCOA/ePRO solutions for clinical trials, including wearable integrations, used by pharma and CROs. Directly competes with Zamplo Research for remote PRO collection and real-world data capture in regulated clinical studies.
- Signant Health (formerly CRF Health): Signant Health specializes in eCOA/ePRO, patient engagement, and decentralized trial technology for pharma-sponsored studies. Comparable to Zamplo Research in serving trial sponsors and CROs with electronic outcome assessments.
- Science 37: Science 37 runs decentralized clinical trials with a connected patient platform for remote PROs and telehealth. Overlaps with Zamplo Research for hybrid/decentralized study designs in pharma-sponsored research.
- Biofourmis: Biofourmis offers a continuous remote patient monitoring platform with wearable integrations and AI-based predictive analytics for chronic and post-acute care. Direct overlap with Zamplo's RPM and AI/ML positioning.
- Vivify Health: Vivify Health provides a remote patient monitoring and care plan platform for chronic disease management and post-acute care. Comparable to Zamplo App for patient-facing self-management and care team engagement.
Broad incumbents
- Medidata (Dassault Systèmes): Medidata's Rave EDC and Patient Cloud ePRO modules are widely used in pharma-led clinical trials. As a broad incumbent with deep integration into CRO workflows, it competes with Zamplo Research at the enterprise end of the ePRO market.
- IQVIA eCOA: IQVIA's eCOA solutions power PROs, ClinROs, and ObsROs across thousands of pharma-sponsored trials, with deep CRO integration. Broad incumbent competing with Zamplo Research for enterprise ePRO contracts.
Emerging players
- Curebase: Curebase delivers decentralized and hybrid clinical trial technology with ePRO, eConsent, and connected devices for sponsors and CROs. Emerging peer in the same ePRO plus wearables wedge as Zamplo Research.
- Evidation Health: Evidation Health operates a real-world patient data and engagement platform connecting consented consumers and wearables for research and health insights. Comparable to Zamplo in capturing consented patient-generated data for research and pharma partnerships.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights7 records
Customer concentration
Zamplo social profiles
Digital presenceZamplo compliance and trust
Trust signalCompliance2 records
Zamplo financial estimates
Financial estimateRevenue estimate
Valuation estimate
Zamplo leadership team
Management profileNumber of profiles
Profiles11 records
Zamplo funding detail
Funding detailFunding overview
Funding rounds4 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Zamplo M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Zamplo
What does Zamplo do?
Zamplo provides a connected health SaaS platform that captures patient-reported outcomes, wearable data, and e-consent remotely to support clinical research, remote patient monitoring, and patient support programs. Its two core offerings are Zamplo Research, a web-based platform for healthcare researchers, providers, and pharmaceutical companies to configure PROMs surveys and extract real-time CSV data, and the Zamplo App, a consumer mobile and desktop application that lets patients and caregivers track symptoms, medications, activities, and health documents. The platform supports specialized deployments such as the Alberta Metastatic Breast Cancer (mBC) Support Platform.
Is Zamplo a public or private company?
Zamplo is a private company. It is classified as venture growth investor backed and is currently operating.
When was Zamplo founded?
Zamplo was founded in 2020. It employs 1 to 10 people.
Where is Zamplo based?
Zamplo is headquartered in Calgary, Canada, in the North America region.
How does Zamplo make money?
One revenue line is on record: zamplo Research Platform Subscription.
Who are Zamplo's main competitors?
Direct peers on record are Castor, Clario, Signant Health (formerly CRF Health), Science 37, Biofourmis and Vivify Health. Broad incumbents are Medidata (Dassault Systèmes) and IQVIA eCOA. Emerging players are Curebase and Evidation Health.
Does Zamplo have an API?
No public API is recorded for Zamplo.
What industry is Zamplo in?
Zamplo's product category is Digital health / Patient-reported outcomes software. Its primary akta.pro industry code is HLALAFAD, Oncology Remote Symptom Monitoring & Care Navigation, with a secondary code of HLAGACAG, Clinical Trial Monitoring Support (On-site/Remote). Its NAICS code is 54151 and its SIC code is 8731.